Keywords: AnGes MG, Mitsubishi Tanabe Pharma, Collategene, US marketing, Peripheral arterial disease, Buerger's disease, USA
AnGes deal with Mitsubishi Tanabe Pharma for Collategene in USA
Article | 04 July 2012
AnGes MG (TYO: 4563) has concluded a basic agreement with fellow Japanese drugmaker Mitsubishi Tanabe Pharma (TYO: 4508) for the exclusive marketing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
